Press Release Healthcare/Medical Devices 1 min read

Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Corvia Medical, a heart failure treatment company, raised $55 million from existing investors to complete the RESPONDER-HF trial and pursue FDA approval for its Corvia Atrial Shunt device.

Third Rock Ventures General Catalyst Partners AccelMed Lumira Ventures Strategic Investor 1 Strategic Investor 2 Corvia Medical Inc
Press ReleaseJune 17, 2025
Third Rock Ventures

Corvia Medical, a heart failure treatment company, raised $55 million from existing investors to complete the RESPONDER-HF trial and pursue FDA approval for its Corvia Atrial Shunt device.

Related articles

Press ReleaseSeptember 16, 2026
ASSA ABLOY

ASSA ABLOY acquires PACLOCK in the US

September 16, 2026
Press ReleaseSeptember 16, 2026
MySize

MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv

Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform

September 16, 2026
← Back to all articles

Generated by Olivia 6